he Oxford hip score (OHS) is a patient-based instrument for assessment of outcome which is often used after total hip replacement, and the EuroQol 5D (EQ5D) is a patient-based generic questionnaire for health assessment. In an analysis of the outcome at one year of 609 revision hip replacements (RHRs), we compared the OHS and EQ5D scores, postoperative patient satisfaction and change in pain. About 25% of the operations were repeat RHRs. At one year, 57% of patients were very pleased with their operation. The correlation between preoperative and postoperative scores and change scores for the OHS and EQ5D was high. For both instruments the effect sizes were large, but the greater effect size of the OHS suggests that it is particularly sensitive to improvements after RHR. The effect scores of the OHS declined with the number of previous RHRs, while those for the EQ5D seemed less sensitive. Our results confirm the value of the OHS in assessing outcome after RHR.
Approximately 14% of total hip replacements (THRs) carried out in the National Health Service (NHS) in the UK are revision procedures. This represents a high cost, and it is therefore important to have effective ways of evaluating and comparing outcomes after revision hip replacement (RHR).
Many long-term (five-to ten-year) follow-up studies of clinical and technological features of RHR define outcome in terms of the annual rate of subsequent revision. 1 This oversimplifies the matter by implying that patients who do not need a further revision have had a good outcome. 2 Information may be obtained directly from patients, whose judgements are often valid, reliable and free from clinical bias. [3] [4] [5] Patient-based measures of health-related quality of life allow large-scale long-term studies of outcome to be carried out. [6] [7] [8] Either condition-specific or generic assessments can be used. The Oxford hip score [4] [5] [6] [7] [8] [9] (OHS) is a 12-item patient-based questionnaire developed and validated specifically to assess function and pain after THR. The EuroQol 5D (EQ5D), a generic instrument for assessing quality of life, identifies 243 possible health states. 10, 11 It is based on five questions about mobility, self-care, usual activity, pain/discomfort and anxiety/depression. There are three possible levels of response for each item. 10, 11 Each state carries a utility value, which is calculated using time trade-offs. Perfect health and death have utility values of one and zero, respectively, and states worse than death ( < 0) are possible. We have evaluated the OHS as an outcome assessment instrument after RHR. First, we compared its validity with that of the EQ5D. Secondly, we examined the sensitivity to change of the two instruments. Sensitivity to change is an important property of an outcome assessment instrument, 12 particularly when, as in the case of RHR, improvement may be marginal. [13] [14] [15] [16] Thirdly, we examined the sensitivity to change of both instruments among subgroups characterised by the number of previous RHRs which had been undertaken.
Patients and Methods
Between September 1996 and April 1999, 609 RHRs were performed at a specialist orthopaedic centre. RHR was defined as removal and replacement of the cup, the stem or both components. To obtain data we used a variety of prepiloted questionnaires and also drew information from the hospital patient administration system. Patients' preoperative questionnaires. About two weeks before surgery, patients completed the OHS and EQ5D questionnaires.
Surgeons' questionnaire. Surgeons provided details of the implant and surgical technique which they used, and of their own grade. Anaesthetists' questionnaire. Anaesthetists recorded the patient's weight and physical status, using the rating of the American Society of Anaesthesiologists (ASA). Questionnaire on postoperative complications. About nine weeks after surgery a clinician in the outpatient department noted whether or not patients had developed any of a number of listed major postoperative complications. Patient-based questionnaires. One year after surgery we asked patients whether they had undergone any operations since their RHR. They were asked also whether they were very pleased, fairly pleased, not very pleased or very disappointed with their operation, and whether their hip was much improved, slightly improved, unchanged, slightly worse or much worse than before surgery. Transition questions, asking patients to compare a current health state with a specified past state, have been shown to be a valid way of assessing outcome. 3, 4, 17 Patients again completed the OHS and EQ5D questionnaires. For each instrument, we calculated change scores (postoperative score minus preoperative score) and effect sizes. The latter measures the extent of change in a standardised way which allows comparison between instruments. 18 To calculate the effect size, we divided the difference between Results Table I shows the questionnaire response rates, which were generally high. Table II gives preoperative details of the patients. For 20 hips, the data were missing. In the remaining 589 hips, the reason for RHR was aseptic loosening in 426 (72%), sepsis in 58 (9.8%) and recurrent dislocation in 40 (6.8%). A further 65 prostheses (11%) were replaced for other reasons, including fracture and pain. Repeat RHR was performed on 152 hips (26%), with 52 patients (9%) undergoing their second, third or fourth RHR.
Details of the component replaced were missing for four of the 609 hips. In 346 (57%) it was necessary to replace both stems and cups. Only the stem was replaced in 112 (19%) and only the cup in 147 (24%). In 54% of first-time RHRs, both components were replaced. Table III shows the high correlation between the preoperative scores for the OHS and EQ5D (r = -0.67, p < 0.001), postoperative scores (r = 0.77, p < 0.001) and change scores (r = 0.59, p < 0.001).
Overall outcomes are given in Table IV . By about nine weeks after surgery, 172 of 516 patients (33%) reported at least one postoperative complication. At one year, 246 of 434 patients (57%) stated that they were very pleased with the results of RHR and 321 (75%) that their hip pain was much improved since the operation. Neither the OHS nor the EQ5D reflected any important age-or gender-related differences. sizes. In line with diminishing patient satisfaction, OHS postoperative scores deteriorated. Both OHS and EQ5D change scores clearly reflected the different levels of patient satisfaction, but there was some overlap in the scores of patients who were not very pleased or very disappointed. The overall effect size was 1.93 and -0.89 for the OHS and the EQ5D, respectively. For those patients who were most pleased, positive changes were reflected in both OHS and EQ5D effect sizes. There were differences between the OHS postoperative scores and change scores of patients whose hip pain had improved since the operation and those who said it was We divided patients into subgroups according to whether their hips had previously been replaced once, twice or more and summarise the results of our analysis in Table VI . With each RHR, the risks both of suffering hip dislocation and of having to undergo another RHR increased. In the first year after surgery, dislocation of the new implant occurred in over a quarter of patients who had undergone two or more previous RHRs and over a third needed a further operation.
The OHS postoperative scores at one year deteriorated progressively in line with the number of previous RHRs (p < 0.001) and the OHS change scores also differed (p = 0.012). The difference in change scores (16.4-11.6 = 4.8) was greatest between patients undergoing RHR for the first time and those who had previously undergone RHR twice or more. The difference remained significant after adjustment for age and gender (p = 0.017). The corresponding effect sizes were 2.11, 1.68 and 1.58 for groups who had undergone RHR once, twice or more, respectively. The EQ5D was less sensitive than the OHS in assessing change if there had been previous RHR. While EQ5D scores progressively deteriorated (p = 0.041), differences in change scores were not significant. The corresponding EQ5D effect sizes were -0.89, -0.78 and -0.87 for patients who had undergone RHR once, twice or more, respectively.
Discussion
For any specific application, the value of an outcome assessment instrument should be tested rather than assumed. To be relevant and useful, it must be demonstrably sensitive to clinically important change. 19 We examined aspects of the OHS by comparing OHS and EQ5D scores, change scores and effect sizes. These instruments reflected considerable variation in outcome after RHR. There was a high level of agreement between OHS and EQ5D preoperative, postoperative and change scores. For both instruments the effect sizes were large, but the greater effect size of the OHS suggests that it is particularly sensitive to improvements after RHR. This is further evidence of its construct validity. 4, 9 One year after RHR we compared the OHS and EQ5D scores with patients' responses about postoperative satisfaction and changes in pain levels. There was a high level of agreement in all four measures. At one year, pain was reported to be much improved in 75% of hips. In the OHS developmental study, dealing chiefly with primary THA, pain was reported to be much improved in 86%.
